Liu Han, Zhang Qin, Wang Sicheng, Weng Weizong, Jing Yingying, Su Jiacan
Institute of Translational Medicine, Shanghai University, Shanghai, 200444, China.
Department of Orthopedics, Shanghai Zhongye Hospital, Shanghai, China.
Bioact Mater. 2021 Dec 17;14:169-181. doi: 10.1016/j.bioactmat.2021.12.006. eCollection 2022 Aug.
Nanosized extracellular vesicles derived from bacteria contain diverse cargo and transfer intercellular bioactive molecules to cells. Due to their favorable intercellular interactions, cell membrane-derived bacterial extracellular vesicles (BEVs) have great potential to become novel drug delivery platforms. In this review, we summarize the biogenesis mechanism and compositions of various BEVs. In addition, an overview of effective isolation and purification techniques of BEVs is provided. In particular, we focus on the application of BEVs as bioactive nanocarriers for drug delivery. Finally, we summarize the advances and challenges of BEVs after providing a comprehensive discussion in each section. We believe that a deeper understanding of BEVs will open new avenues for their exploitation in drug delivery applications.
Microb Pathog. 2023-10
Nano Converg. 2024-7-11
Sci Total Environ. 2024-1-10
J Microbiol Biotechnol. 2025-8-26
Vaccines (Basel). 2025-7-20
Int J Mol Sci. 2025-5-23
J Extracell Vesicles. 2021-11
J Extracell Vesicles. 2021-10
Nat Nanotechnol. 2021-7
Trends Microbiol. 2021-12
Int J Mol Sci. 2021-4-19
Bioact Mater. 2021-2-23